Amaryl, Glimepiride News

There are new concerns about an older class of diabetes medications. A large study looked at seniors who were taking a specific class of diabetes drugs.

A class of drugs still taken by millions of people with type 2 diabetes is associated with a higher risk of dying and heart failure than the newer treatment metformin, researchers say.

Four widely prescribed oral sulfonylurea drugs are associated with significantly increased risk of all-cause mortality compared with metformin in type 2 diabetic patients having a history of MI, according to a comprehensive Danish national cohort study.

Updated May 17, 2006 Insulin Resistance A condition in which the body needs extra insulin to maintain normal blood sugar levels.

Updated May 17, 2006 Insulin Resistance A condition in which the body needs extra insulin to maintain normal blood sugar levels.

Updated May 17, 2006 Insulin Resistance A condition in which the body needs extra insulin to maintain normal blood sugar levels.

The data were presented at the 114th National Medical Association Annual Convention & Scientific Assembly.

An experimental diabetes drug called liraglutide appears to outperform exenatide , the only currently approved drug in its class, a study funded by liraglutide's maker, Novo Nordisk, shows.

Novo Nordisk A/S's experimental diabetes drug liraglutide was significantly better at helping patients control blood sugar than an older common medicine after two years of treatment, according to data from a clinical trial.

Novo Nordisk data presented today at the 69th Annual Scientific Sessions of the American Diabetes Association showed that once-daily liraglutide, taken as monotherapy, leads to statistically significant and sustained reductions in blood sugar and weight after two years of treatment.

Links not loading properly? Some of our pages use Portable Document Format files, which require Adobe Acrobat Reader.